Wag has agreed to buy back almost 50% of its shares from SoftBank, who invested $300m last year but which is selling at a loss.

Pharmaron-backed Zentalis Pharmaceuticals has now secured $147m altogether and will advance its breast cancer and solid tumour candidates through clinical trials.

Hiscox is set to exit digital insurance processing platform Indio Technologies in an acquisition by Applied Systems that follows $28m in venture funding.

Alexandria Venture Investments has backed a series A round for Jasper Therapeutics, which is developing a conditioning agent for patients awaiting stem cell transplants.

Agilent Technologies contributed to a $50m round for the tissue-imaging technology developer, which has earmarked the funds for product development.

Mobile bank operator Chime has closed a $500m series E round at a $5.8bn valuation – an increase of $4.3bn in nine months – backed by Access Industries.

AutoNation-backed Vroom has now raised $721m in funding altogether after closing a $254m series H round led by Durable Capital Partners.

Plexo Capital, a venture capital spinoff from Alphabet subsidiary GV, has raised $42.5m from LPs that include Alphabet, Intel Capital and Cisco Investments.

Building on translational science from Stanford, Jasper has secured funding to progress its Amgen-licensed conditioning agent for patients awaiting stem cell transplants.

PLT Health Solutions and existing backer Tate & Lyle Ventures contributed to a $12.7m round for vegan ingredients supplier Nutriati to take its total funding to more than $22m.